Scandinavian Journal of Urology最新文献

{"title":"Non-transecting urethroplasty in patients with bulbar urethral strictures shorter than three centimeters.","authors":"Muhammet Şahin Yılmaz,&nbsp;Alihan Kokurcan,&nbsp;Fahrettin Şamil Uysal,&nbsp;Görkem Özenç,&nbsp;Fatih Yalçınkaya","doi":"10.1080/21681805.2022.2147993","DOIUrl":"https://doi.org/10.1080/21681805.2022.2147993","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to compare the success and postoperative complication rates of the novel non-transecting urethroplasty (NTU) technique and conventional excision-primary anastomosis (EPA) in the surgical treatment of short bulbar urethral strictures.</p><p><strong>Material and methods: </strong>Data of the patients who underwent excision-primary anastomosis or NTU procedures at our center for the surgical treatment of bulbar urethral strictures shorter than 3 cm between January 2010 and December 2018 were retrospectively reviewed.</p><p><strong>Results: </strong>Forty-seven patients fulfilled the eligibility criteria for this study. Among these patients, 22 underwent NTU procedure while 25 underwent EPA. There was no difference between the two groups regarding age, stricture length, etiology, past surgical history, and duration of follow-up. The surgical success rates were 88% and 87,2% in the NTU and EPA groups, respectively (<i>p</i> = 0,603). The complication rates were 12% and 13,6% in NTU and EPA groups, respectively. Two groups were similar concerning complication rates (<i>p</i> = 0,603).</p><p><strong>Conclusion: </strong>The novel NTU and conventional EPA techniques are similar regarding surgical success and complication rates in the surgical treatment of bulbar urethral strictures shorter than three centimeters.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"97-101"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10772665","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"UROSCAN and UROSCANSEQ: a large-scale multicenter effort towards translation of molecular bladder cancer subtypes into clinical practice - from biobank to RNA-sequencing in real time.","authors":"Fredrik Liedberg,&nbsp;Johan Abrahamsson,&nbsp;Carina Bernardo,&nbsp;Mats Bläckberg,&nbsp;Anders Edsjö,&nbsp;Markus Heidenblad,&nbsp;Christer Larsson,&nbsp;Gottfrid Sjödahl,&nbsp;Pontus Eriksson","doi":"10.1080/21681805.2022.2159519","DOIUrl":"https://doi.org/10.1080/21681805.2022.2159519","url":null,"abstract":"<p><strong>Background: </strong>Bladder cancer is molecularly one of the most heterogenous malignancies characterized by equally heterogenous clinical outcomes. Standard morphological assessment with pathology and added immunohistochemical analyses is unable to fully address the heterogeneity, but up to now treatment decisions have been made based on such information only. Bladder cancer molecular subtypes will likely provide means for a more personalized bladder cancer care.</p><p><strong>Methods: </strong>To facilitate further development of bladder cancer molecular subtypes and clinical translation, the UROSCAN-biobank was initiated in 2013 to achieve systematic biobanking of preoperative blood and fresh frozen tumor tissue in a population-based setting. In a second phase, we established in 2018 a parallel logistic pipeline for molecular profiling by RNA-sequencing, to develop and validate clinical implementation of molecular subtyping and actionable molecular target identification in real-time.</p><p><strong>Results: </strong>Until June 2021, 1825 individuals were included in the UROSCAN-biobank, of which 1650 (90%) had primary bladder cancer, 127 (7%) recurrent tumors, and 48 (3%) unknown tumor status. In 159 patients, multiple tumors were sampled, and metachronous tumors were collected in 83 patients. Between 2016 and 2020 the UROSCAN-biobanking included 1122/2999 (37%) of all primary bladder cancer patients in the Southern Healthcare Region. Until June 2021, the corresponding numbers subjected to RNA-sequencing and molecular subtyping was 605 (UROSCANSEQ), of which 52 (9%) samples were not sequenced due to inadequate RNA-quality (<i>n</i> = 47) or technical failure/lost sample (<i>n</i> = 5).</p><p><strong>Conclusions: </strong>The UROSCAN-biobanking and UROSCANSEQ-infrastructure for molecular subtyping by real-time RNA-sequencing represents, to our knowledge, the largest effort of evaluating population-wide molecular classification of bladder cancer.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"2-9"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10777135","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Incidence and associated risk factors of venous thromboembolism after open and laparoscopic partial nephrectomy in patients administered short-period thromboprophylaxis: a Danish nationwide population-based cohort study.","authors":"Nessn H Azawi,&nbsp;Sara Tolouee,&nbsp;Saeed Dabestani","doi":"10.1080/21681805.2023.2171112","DOIUrl":"https://doi.org/10.1080/21681805.2023.2171112","url":null,"abstract":"<p><strong>Objective: </strong>To report the risk of venous thromboembolism (VTE) after partial nephrectomy in Denmark.</p><p><strong>Materials and methods: </strong>A nationwide population-based registry was used to conduct a retrospective cohort study. All partial nephrectomies from January 2010 to August 2018 were assessed for postoperative VTE events. Univariable and multivariable analyses were used to evaluate the odds of postoperative VTE within 4 weeks and 4 months after partial nephrectomy in patients who received standard-of-care thromboprophylaxis.</p><p><strong>Results: </strong>Among 2355 patients, postoperative VTE risk was 0.6% and 0.9%, at 4 weeks and 4 months, respectively. In multivariate analysis, prior VTE (OR = 24.9, <i>p</i> < 0.001) and length of hospital stay (OR = 0.89, <i>p</i> < 0.001) were predictors of postoperative VTE within 4 months after partial nephrectomy. Limitations included the retrospective and registry-based study design and the absence of BMI data.</p><p><strong>Conclusion: </strong>Incidence of postoperative VTE is rare, but patients with prior VTE and those with a greater length of hospital stay are at greater long-term risk and should be evaluated when considering thromboprophylaxis.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"81-85"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10777360","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Register-based research. Accurate data and analysis, crucial for correct conclusions. Comment on \"Incidence, mortality, and relative survival of patients with cancer of the bladder and upper urothelial tract in the Nordic countries between 1990 and 2019\".","authors":"Marianne Brehmer","doi":"10.1080/21681805.2022.2154384","DOIUrl":"https://doi.org/10.1080/21681805.2022.2154384","url":null,"abstract":"","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"22-23"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9626148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Low-volume grade group 2 prostate cancer candidates for active surveillance: a radical prostatectomy retrospective analysis.","authors":"Johan Björklund,&nbsp;Douglas C Cheung,&nbsp;Lisa J Martin,&nbsp;Maria Komisarenko,&nbsp;Katharine Lajkosz,&nbsp;Robert J Hamilton,&nbsp;Alexandre R Zlotta,&nbsp;Antonio Finelli","doi":"10.1080/21681805.2023.2165709","DOIUrl":"https://doi.org/10.1080/21681805.2023.2165709","url":null,"abstract":"<p><strong>Objective: </strong>Guidelines support considering selected men with ISUP grade group (GG) 2 prostate cancer for active surveillance (AS). We assessed the association of clinical variables with unfavorable pathology at radical prostatectomy in low-volume GG 2 prostate cancer on biopsy in a retrospective cohort.</p><p><strong>Materials and methods: </strong>This was a retrospective analysis of 378 men with low-volume (≤ 2 cores) GG 2 localized prostate cancer who underwent prostatectomy at a single tertiary cancer center. Multivariable logistic regression of unfavorable pathology, upgrading to ≥ T3, or GG ≥ 3 was performed in relation to clinical factors, common variables used in AS in GG 1 and percentage Gleason 4 at biopsy. We compared the performance of potential variables with commonly used combined AS restrictions in GG 1 prostate cancer.</p><p><strong>Results: </strong>In total, 128/378 (34%) men had unfavorable pathology at radical prostatectomy. On multivariable analysis, > 5% Gleason pattern 4 was independently associated with an increased risk of GG ≥ 3. A maximum percentage core involvement > 50% was independently associated with an increased risk of pT-stage ≥ 3 and unfavorable pathology. Restriction to patients with ≤ 5% Gleason 4 decreased the upgrading of both unfavorable pathology (OR = 0.62, <i>p</i> = 0.041) and GG ≥ 3 (OR = 0.17, <i>p</i> = 0.0007) compared to the full cohort, while restriction to those with ≤ 50% of max core involvement did not.</p><p><strong>Conclusion: </strong>In low-volume GG 2, the percentage of Gleason 4 of ≤ 5% was the strongest predictor in reducing upgrading at final pathology. This easily available pathological descriptor could be used to guide urologists and patients when considering AS in this setting.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"29-35"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10766522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Onset of androgen deprivation therapy leads to rapid deterioration of body composition, physical performance, cardiometabolic health and quality-of-life in prostate cancer patients.","authors":"Maarten Overkamp,&nbsp;Lisanne H P Houben,&nbsp;Saskia van der Meer,&nbsp;Joep G H van Roermund,&nbsp;Ronald Bos,&nbsp;Arjan P J Kokshoorn,&nbsp;Mads S Larsen,&nbsp;Luc J C van Loon,&nbsp;Milou Beelen,&nbsp;Sandra Beijer","doi":"10.1080/21681805.2023.2168050","DOIUrl":"https://doi.org/10.1080/21681805.2023.2168050","url":null,"abstract":"<p><strong>Objectives: </strong>To assess the adverse impact of the first 5 months of androgen deprivation therapy on body composition, physical performance, cardiometabolic health and health-related quality-of-life in prostate cancer patients.</p><p><strong>Materials and methods: </strong>Thirty-four prostate cancer patients (70 ± 7 years) were assessed shortly after initiation of androgen deprivation therapy and again 5 months thereafter. Measurements consisted of whole-body dual-energy x-ray absorptiometry (body composition), computed tomography scanning of the upper leg (muscle mass), one-repetition maximum leg press (muscle strength), cardiopulmonary exercise testing (aerobic capacity), blood draws (metabolic parameters), accelerometry (habitual physical activity) and questionnaires (health-related quality-of-life). Data were analyzed with Student's paired <i>t</i>-tests.</p><p><strong>Results: </strong>Over time, whole-body fat mass (from 26.2 ± 7.7 to 28.4 ± 8.3 kg, <i>p</i> < 0.001) and fasting insulin (from 9.5 ± 5.8 to 11.3 ± 6.9 mU/L, <i>p</i> < 0.001) increased. Declines were observed for quadriceps cross-sectional area (from 66.3 ± 9.1 to 65.0 ± 8.5 cm², <i>p</i> < 0.01), one-repetition maximum leg press (from 107 ± 27 to 100 ± 27 kg, <i>p</i> < 0.01), peak oxygen uptake (from 23.2 ± 3.7 to 20.3 ± 3.4 mL/min/kg body weight, <i>p</i> < 0.001), step count (from 7,048 ± 2,277 to 5,842 ± 1,749 steps/day, <i>p</i> < 0.01) and health-related quality-of-life (from 84.6 ± 13.5 to 77.0 ± 14.6, <i>p</i> < 0.001).</p><p><strong>Conclusions: </strong>Androgen deprivation therapy induces adverse changes in body composition, muscle strength, cardiometabolic health and health-related quality-of-life already within 5 months after the start of treatment, possibly largely contributed by diminished habitual physical activity. Prostate cancer patients should, therefore, be stimulated to increase their habitual physical activity immediately after initiation of androgen deprivation therapy, to limit adverse side-effects and to improve health-related quality-of-life.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"60-66"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10777359","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of complications after transperineal and transrectal prostate biopsy using a risk-stratified pathway identifying patients at risk for post-biopsy infections.","authors":"Sebastian Berg,&nbsp;Karl Heinrich Tully,&nbsp;Vincent Hoffmann,&nbsp;Henning Bahlburg,&nbsp;Florian Roghmann,&nbsp;Guido Müller,&nbsp;Joachim Noldus,&nbsp;Moritz Reike","doi":"10.1080/21681805.2023.2168049","DOIUrl":"https://doi.org/10.1080/21681805.2023.2168049","url":null,"abstract":"<p><strong>Introduction: </strong>Evidence of transperineal (TP) superiority over transrectal (TR) biopsy is growing due to lower infectious complication rates. However, TR biopsy is the most common procedure, and it seems that a cross-over to TP is delayed by logistical challenges such as costs, complexity, and lack of experience. We investigate whether well-selected patients without any risk factors may further undergo TR biopsy if all precautions to avoid infections are warranted.</p><p><strong>Materials and methods: </strong>Data were collected in our academic institution between August 2021 and March 2022 and after clinical implementation of the currently updated European Association of Urology guideline recommendations on the performance of prostate biopsy. Patients underwent either TP or TR biopsy according to a riskstratification based on risk factors of infectious complications. Follow-up asked for post-biopsy complications. Inverse Probability of Treatment Weighting (IPTW) propensity score was used to balance baseline characteristics. Complications were subdivided into infectious and non-infectious complications.</p><p><strong>Results: </strong>In total, 294 patients were included with 161 patients undergoing TR vs. 133 patients undergoing TP biopsy. Complication rates were 2.2% for TP vs. 5.5% for TR biopsy concerning all complications. Infectious complication rates only were 0.7% for TP vs. 1.8% for TR biopsy. After IPTW adjustment, differences were statistically significant different (<i>p</i> = 0.01).</p><p><strong>Conclusion: </strong>Our study revealed that even in a well-selected patient cohort with presumably lower risk of infectious complications, TR biopsy leads to more post-biopsy complications than TP biopsy. This conclusion should motivate the urological community to switch to TP biopsy.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"41-46"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9340414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Feasibility of minimally invasive, same-day injection of autologous adipose-derived stem cells in the treatment of erectile dysfunction.","authors":"Mikkel Fode,&nbsp;Naomi Nadler,&nbsp;Lars Lund,&nbsp;Nessn Azawi","doi":"10.1080/21681805.2022.2162117","DOIUrl":"https://doi.org/10.1080/21681805.2022.2162117","url":null,"abstract":"<p><strong>Objective: </strong>To investigate feasibility and safety of a new minimally invasive same-day method of autologous adipose derived stem cell (ADSC) transplantation in men suffering from ED.</p><p><strong>Materials and methods: </strong>Prospective case series of 10 men with an IIEF-EF domain score <17. The IIEF questionnaire was filled out at baseline and 1, 2 and 3 months after treatment. Side effects were assessed by investigations and interviews until 6 months after treatment. The myStem® X2 kit was used for preparation of ADSC: Adipose tissue was harvested from the patient himself under local anesthesia and immediately prepared and injected into the penis. Primary endpoints were feasibility and safety. Secondary outcomes included effects on ED and changes in the remaining IIEF domains.</p><p><strong>Results: </strong>Ten men were included. Only one adverse event in the form of minor blue discoloration at the fat harvest site was registered. There were statistically significant improvements in IIEF-EF at one, two and three months after treatment compared to baseline with the median score increasing from 5.5 to 10.5, 10.5 and 10, respectively. Considering the individual patients, 3/10 men achieved an improvement equal to or greater than the minimal clinically important difference according to their baseline IIEF-EF score.</p><p><strong>Conclusions: </strong>Our study confirms the feasibility and safety of this minimally invasive, same-day delivery of ADSC. Due to the design and size on the study, conclusions should not be drawn regarding efficacy, but the method seems worthy of further study.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"110-114"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10777592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Women's experience of sexuality after radical cystectomy - a qualitative study.","authors":"Annica Löfgren,&nbsp;Karin Stenzelius,&nbsp;Fredrik Liedberg,&nbsp;Anne-Marie Wangel","doi":"10.1080/21681805.2022.2157872","DOIUrl":"https://doi.org/10.1080/21681805.2022.2157872","url":null,"abstract":"<p><strong>Purpose: </strong>The aim of this study was to explore how women experienced sexuality after radical cystectomy due to bladder cancer.</p><p><strong>Methods: </strong>We performed an interview study with qualitative design with content analysis. Inclusion criteria were age below 75 years. In total 10 women, with a median age of 64 years at surgery, were interviewed at median 24 months post radical cystectomy.</p><p><strong>Results: </strong>The 10 women described sexual life as affected after surgery but they all tried to find ways to overcome the new situation together with their partner. The overall theme was 'A balance between emotional and physical closeness' emerged from 30 codes that were condensed into five subcategories and two categories: 'A sensual relationship' and 'A sexual relationship'. The first category constituted the subcategories 'Feeling of intimacy' and 'The importance of the relationship'. The category 'A sexual relationship' was revealed from the subcategories 'Reluctance to engage in sexual activity' and 'Partner inability to engage in sexual activity', and 'Acting for sexual rehabilitation'.</p><p><strong>Conclusions: </strong>The uncertainty that the women felt about their anatomical changes after radical cystectomy created a sexual anxiety and reluctance to resume intercourse. Even though the surgery had a major impact on their sexual life, the women tried to be sexually active. However, the meaning of sexual life was not just having sexual activity but also included closeness, affirmation, affection, and feeling attractive. Sexual counseling at an appropriate timepoint is essential to assure a balance between emotional and physical closeness, i.e. to regain sexual health.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"24-28"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10776355","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lower urinary tract injuries in patients with pelvic fractures at a level 1 trauma center - an 11-year experience.","authors":"Lasse Rehné Jensen,&nbsp;Andreas Røder,&nbsp;Emma Possfelt-Møller,&nbsp;Upender Martin Singh,&nbsp;Mikael Aagaard,&nbsp;Allan Evald Nielsen,&nbsp;Lars Bo Svendsen,&nbsp;Luit Penninga","doi":"10.1080/21681805.2022.2141311","DOIUrl":"https://doi.org/10.1080/21681805.2022.2141311","url":null,"abstract":"<p><strong>Background: </strong>Urological injuries can occur in patients with pelvic fractures. Treatment recommendations lack solid evidence and is often pragmatical. There is a continuous need to describe short- and long-term morbidity following lower urinary tract trauma.</p><p><strong>Objective: </strong>To describe incidence, diagnosis, treatment, and morbidity following lower urinary tract injuries in pelvic fractures.</p><p><strong>Patients and methods: </strong>Retrospective study including patients with pelvic, including acetabular, fractures admitted to a Level I Trauma Centre covering 2.8 million citizens between 2009 and 2020. Outcome measurements comprised primary management, treatment trajectory, short- and long-term complications and outcomes.</p><p><strong>Results: </strong>A total of 39 (5%) patients with pelvic fractures had concomitant urethral and/or bladder injuries, and one patient with an acetabular fracture had a bladder injury. The management of urethral injuries varied vastly, and complete urethral ruptures were associated with severe short- and long-term complications. Only one patient with bladder injury experienced severe long-term complications.</p><p><strong>Conclusions: </strong>Management of lower urinary tract injuries in patients with major pelvic fractures remains a major challenge. Special attention should be focused on urethral injuries where we uncovered an unsystematic treatment and follow-up even in a highly experienced centre, although this is also attributed to complicated multidisciplinary patient trajectories. There is a continuous need to reduce long-term complications following urethral trauma which should be addressed in multicenter studies.</p>","PeriodicalId":21542,"journal":{"name":"Scandinavian Journal of Urology","volume":"57 1-6","pages":"102-109"},"PeriodicalIF":1.5,"publicationDate":"2023-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10781402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}